Insulin Pens Market

Insulin Pens Market contains market size and forecasts of Insulin Pens in global, including the following market information:

• Global Insulin Pens Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Insulin Pens Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Insulin Pens companies in 2021 (%)

The global Insulin Pens market was valued at 4520.8 million in 2021 and is projected to reach US$ 13700 million by 2028, at a CAGR of 17.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Standard Insulin Pen Needles Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Insulin Pens include BD, Novo Nordisk, Artsana, B. Braun, Terumo, Ypsomed, Owen Mumford, HTL-Strefa and Beipu, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Insulin Pens manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Insulin Pens Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Insulin Pens Market Segment Percentages, by Type, 2021 (%)

• Standard Insulin Pen Needles
• Safety Insulin Pen Needles

Global Insulin Pens Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Insulin Pens Market Segment Percentages, by Application, 2021 (%)

• Home Use
• Medical Institutions
• Others

Global Insulin Pens Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Insulin Pens Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Insulin Pens revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Insulin Pens revenues share in global market, 2021 (%)
• Key companies Insulin Pens sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Insulin Pens sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• BD
• Novo Nordisk
• Artsana
• B. Braun
• Terumo
• Ypsomed
• Owen Mumford
• HTL-Strefa
• Beipu
• Kangdelai
• Ulticare
• Allison Medical
• Dongbao